Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cresco Labs (CRLBF) Equity Average (2020 - 2026)

Cresco Labs filings provide 7 years of Equity Average readings, the most recent being $248.4 million for Q1 2026.

  • On a quarterly basis, Equity Average fell 41.59% to $248.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $248.4 million, a 41.59% decrease, with the full-year FY2025 number at $363.7 million, down 19.44% from a year prior.
  • Equity Average hit $248.4 million in Q1 2026 for Cresco Labs, down from $296.3 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $777.5 million in Q3 2022 to a low of $248.4 million in Q1 2026.
  • Median Equity Average over the past 5 years was $425.2 million (2025), compared with a mean of $490.5 million.
  • Biggest five-year swings in Equity Average: rose 28.36% in 2022 and later tumbled 41.59% in 2026.
  • Cresco Labs' Equity Average stood at $679.6 million in 2022, then tumbled by 37.17% to $427.0 million in 2023, then dropped by 1.61% to $420.1 million in 2024, then dropped by 29.46% to $296.3 million in 2025, then dropped by 16.19% to $248.4 million in 2026.
  • The last three reported values for Equity Average were $248.4 million (Q1 2026), $296.3 million (Q4 2025), and $350.5 million (Q3 2025) per Business Quant data.